Entera Bio LTD Schedule 13G passive stakes

Longitude Capital Partners V, LLC and related entities report a 4.6% beneficial ownership stake in Entera Bio Ltd. ordinary shares.

Seven Fleet Horizon Master Fund LP, Seven Fleet Master Fund LP, Seven Fleet Capital Management LP, Seven Fleet Capital Management GP LLC, and Brian Liu have collectively reported a change in their beneficial ownership of Entera Bio, Ltd. ordinary shares.

TCG Crossover Fund III, L.P., TCG Crossover GP III, LLC, and Chen Yu have jointly filed a Schedule 13G, reporting beneficial ownership of 12,254,901 ordinary shares, representing 7.1% of Entera Bio Ltd.'s outstanding shares.

Several Vivo Opportunity entities have updated their beneficial ownership filings for Entera Bio Ltd., reflecting significant holdings and voting power.

Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, reported a 2.6% beneficial ownership stake in Entera Bio Ltd. as of September 30, 2025.

OPKO Health, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 8.1% of Entera Bio Ltd.'s ordinary shares, totaling 3,685,226 shares, as of March 16, 2025.

Point72 Asset Management, along with its affiliates and founder Steven A. Cohen, has disclosed a passive 6.8% beneficial ownership stake in Entera Bio Ltd., totaling 2,701,560 ordinary shares.